Key Features
Free; 1.25 CME; 75 minutes to complete; treatment of plaque psoriasis;
Topics Covered
dermatologists; pediatric dermatologists; plaque psoriasis;
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Summarize the latest research developments in the treatment of plaque psoriasis
- Describe how new data and recommendations can impact clinical practices to improve care
- Incorporate evidence-based research into clinical practice
Target Audience
dermatologists and pediatric dermatologists
Additional credit info
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the materials, reflecting on its implications in your practice, and completing the assessment component. The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented. This educational activity is supported by an educational grant from AbbVie, Janssen Biotech, Inc, administered by Janssen Scientific Affairs, LLC, and Novartis Pharmaceuticals Corp. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.